Sulforaphane in a New Jersey (NJ) Population of Individuals With Autism

Clinical trial NCT02677051 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02677051
Sponsor: Rutgers, The State University of New Jersey
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Autism Autistic Disorder Autism Spectrum Disorder Autistic Behavior

Start date: 2016-02-01
Primary completion: 2025-12-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.